Cargando...
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum of disorders including simple steatosis, characterized by the presence of hepatic steatosis with minimal inflammation,...
Gardado en:
| Publicado en: | Metabolism |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529729/ https://ncbi.nlm.nih.gov/pubmed/32387227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2020.154259 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|